INTRA-CELLULAR THERAPIES INC (ITCI)
US46116X1019 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -110.87M | -139.67M | -256.26M | -284.13M | -227.01M | |||
| Depreciation Amortization | 530.00K | 528.00K | 660.00K | 530.00K | 530.00K | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | 0.00 | 260.00K | |||
| Change In Working Capital | -35.23M | -29.58M | -58.14M | -6.35M | -27.54M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 162.00K | 10.00K | 10.00K | 0.00 | |||
| Other non cash items | 47.33M | 44.52M | 43.55M | 30.40M | 23.68M | |||
| OPERATING CASH FLOW | -98.25M | -124.20M | -270.19M | -259.54M | -230.07M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -269.00K | -780.00K | -330.00K | -270.00K | |||
| Other Investing Activity | 138.45M | 105.81M | -127.60M | 280.67M | -480.03M | |||
| INVESTING CASH FLOW | 138.18M | 105.54M | -128.37M | 280.34M | -480.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 24.16M | 17.81M | 455.16M | 11.52M | 664.18M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 24.16M | 17.81M | 455.16M | 11.52M | 664.18M | |||
| CHANGE IN CASH | 64.09M | -848.00K | 56.60M | 32.32M | -46.19M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -98.25M | -124.20M | -270.19M | -259.54M | -230.07M | |||
| Capital Expenditure | N/A | -269.00K | -780.00K | -330.00K | -270.00K | |||
| FREE CASH FLOW | -98.51M | -124.47M | -270.97M | -259.87M | -230.34M | |||
All data in USD